Biotech Archives - Page 37 of 60 - Life Sciences Times

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

June 7, 2025

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

THIS WEEK'S STORIES

Affinia Therapeutics and DCM Foundation Launch Awareness Campaign for Genetic Heart Disease BAG3 DCM

June 3, 2025

Acerand Therapeutics Begins First-in-Human Trial of ACE-232 for Advanced Prostate Cancer

June 5, 2025

Wolters Kluwer Survey Finds Health Systems Unprepared to Fully Leverage Generative AI

June 3, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

IDEXX Launches In-Clinic Cortisol Test to Help Veterinarians Diagnose Canine Endocrine Disorders

Bruker Showcases Next-Generation Mass Spectrometry Innovations at ASMS 2025

FDA Grants Platform Technology Designation to Sarepta’s Viral Vector Used in SRP-9003 Gene Therapy

TriLink and Quantoom Partner to Expand Access to mRNA Vaccines and Therapeutics Globally

Washington-Area Emergency Responders Equip Hazardous Materials Teams with 908 Devices’ XplorIR Gas Analyzers

Most Read

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

AI-Powered Tool Set to Revolutionize Type 1 Diabetes Diagnosis and Treatment

ZEISS CLARUS 700 Retinal Imaging System Receives Approval in China

Vera Whole Health and Anthem Expand Primary Care Access in Richmond Amid Physician Shortage

EDITOR PICKS

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

THIS WEEK'S STORIES

Affinia Therapeutics and DCM Foundation Launch Awareness Campaign for Genetic Heart Disease BAG3 DCM

Acerand Therapeutics Begins First-in-Human Trial of ACE-232 for Advanced Prostate Cancer

Wolters Kluwer Survey Finds Health Systems Unprepared to Fully Leverage Generative AI

POPULAR CATEGORY

ABOUT US

FOLLOW US